@article{d1f8737245ce424fb0fdeaaf020fb94b,
title = "Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?",
keywords = "CLL, Chemoimmunotherapy, Chronic lymphocytic leukemia, Fixed-duration therapy, MRD, Minimal residual disease, Targeted agents",
author = "Othman Al-Sawaf and Seymour, {John F.} and Kater, {Arnon P.} and Kirsten Fischer",
note = "Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = aug,
doi = "https://doi.org/10.1016/j.hoc.2021.03.007",
language = "English",
volume = "35",
pages = "775--791",
journal = "Hematology/oncology clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "4",
}